Stay updated on GT90001+Nivolumab in Metastatic HCC Clinical Trial

Sign up to get notified when there's something new on the GT90001+Nivolumab in Metastatic HCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GT90001+Nivolumab in Metastatic HCC Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Footer updates include the addition of Revision: v3.3.3 and the removal of HHS Vulnerability Disclosure and Revision: v3.3.2.
    Difference
    0.1%
    Check dated 2025-12-23T10:10:48.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    30 days ago
    Change Detected
    Summary
    Added an Auto-PubMed note indicating publications are automatically filled from PubMed and may not be about the study, and updated the page revision to v3.3.2; removed the older PubMed note and revision v3.2.0.
    Difference
    0.1%
    Check dated 2025-11-24T21:22:39.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    The operating-status notice about government funding has been removed from the page. The clinical trial details and eligibility criteria remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-17T19:11:39.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Updated the site location label from 'Tainan City, Taiwan' to 'Tainan, Taiwan' in the Locations section.
    Difference
    0.1%
    Check dated 2025-11-10T17:20:54.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    The study record appears updated with minor textual clarifications and a refreshed last-updated date, while the primary trial details and listed sites remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T13:22:42.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    Major update: operating-status notice and new version v3.2.0; old v3.1.0 reference removed.
    Difference
    4%
    Check dated 2025-10-06T04:16:07.000Z thumbnail image

Stay in the know with updates to GT90001+Nivolumab in Metastatic HCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GT90001+Nivolumab in Metastatic HCC Clinical Trial page.